Foghorn Therapeutics, Inc. (FHTX)
6.02
-0.26
(-4.14%)
USD |
NASDAQ |
Jan 16, 16:00
6.005
-0.02
(-0.25%)
After-Hours: 20:00
Foghorn Therapeutics Market Cap: 340.44M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GT Biopharma, Inc. | 7.932M |
| Recursion Pharmaceuticals, Inc. | 2.431B |
| Erasca, Inc. | 2.729B |
| OmniAb, Inc. | 273.52M |
| CEL-SCI Corp. | 15.63M |
Market Cap Related Metrics
| PS Ratio | 15.01 |
| Price | 6.02 |
| Earnings Yield | -19.71% |